[1]
Ramalho, D. et al. 2021. Secukinumab, Pituitary Enlargement and Panhypopituitarism: Are They Related? European Journal of Case Reports in Internal Medicine. 8, 12 (Dec. 2021). DOI:https://doi.org/10.12890/2021_003099.